Peptron Competitors and Similar CompaniesClear all
Peptron's competitors and similar companies include PolarityTE, Synthekine, NovellusDx and Generon.
 PolarityTE PolarityTE, Inc. is a regenerative medicine company positioned to be the first to successfully regenerate human skin. |  Synthekine Synthekine is a biotechnology company that specializes in the discovery and development of cytokine therapeutics. |  NovellusDx NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression. |  Generon Generon is a biotechnology company that develops and distributes advanced chemical and biological analysis systems for food safety and environmental monitoring. | ||
Founding Date | Founding Date 1997 | Founding Date 1986 | Founding Date 2019 | Founding Date 2012 | Founding Date 2007 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Salt Lake City, US HQ Salt Lake City, US | Locations Menlo Park, US HQ | Locations Jerusalem, IL HQ Philadelphia, US | Locations San Prospero, IT HQ |
Employees | Employees N/A | Employees 15627% increase | Employees 851% increase | Employees 49 | Employees 186% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) ₩5.6b (FY, 2025) | Revenue (est.) $814k (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ₩1.9b (FY, 2025) | Cost of goods $616k (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ₩3.7b (FY, 2025) | Gross profit $198k (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income (₩13.8b) (FY, 2025) | Net income ($7.8m) (FY, 2022) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 100m (over 3 years ago) | Latest funding round $ 6m (about 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 100m | Total funding raised $ 34.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
PolarityTE
HQ
Salt Lake City, US
Employees
156↑ 27% increase
PolarityTE, Inc. is a regenerative medicine company positioned to be the first to successfully regenerate human skin.
View companySynthekine
HQ
Menlo Park, US
Employees
85↑ 1% increase
Synthekine is a biotechnology company that specializes in the discovery and development of cytokine therapeutics.
View companyNovellusDx
HQ
Jerusalem, IL
Employees
49
NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression.
View companyGeneron
HQ
San Prospero, IT
Employees
18↑ 6% increase
Generon is a biotechnology company that develops and distributes advanced chemical and biological analysis systems for food safety and environmental monitoring.
View company